Literature DB >> 23026934

Ampullary region carcinomas: definition and site specific classification with delineation of four clinicopathologically and prognostically distinct subsets in an analysis of 249 cases.

Volkan Adsay1, Nobuyuki Ohike, Takuma Tajiri, Grace E Kim, Alyssa Krasinskas, Serdar Balci, Pelin Bagci, Olca Basturk, Sudeshna Bandyopadhyay, Kee-Taek Jang, David A Kooby, Shishir K Maithel, Juan Sarmiento, Charles A Staley, Raul S Gonzalez, So Yeon Kong, Michael Goodman.   

Abstract

Ampullary (AMP) carcinomas comprise a heterogeneous group of cancers lacking adequate subcategorization. In the present study, 249 strictly defined primary AMP carcinomas (ACs) identified in 1469 malignant pancreatoduodenectomy specimens were analyzed for defining features. Gross and microscopic findings were used to determine tumor epicenter and extent of preinvasive component. ACs were classified into 4 distinct subtypes based on location: (1) Intra-AMP (25%): Invasive carcinomas arising in intra-ampullary papillary-tubular neoplasms with zero to minimal, duodenal surface involvement (<25% of the tumor). These tumors were more commonly found in men, they had a relatively large overall size (mean, 2.9 cm) but had smaller invasive component (mean, 1.5 cm), and were predominantly of a lower TNM stage (85%, T1/2; and 72% N0). They carried the best prognosis among the 4 groups (3-y survival, 73%). (2) AMP-ductal (15%): These were tumors forming constrictive, sclerotic, plaque-like thickening of the walls of the common bile duct and/or pancreatic duct resulting in mucosa-covered, button-like elevations of the papilla into the duodenal lumen. There was no significant exophytic (preinvasive) growth. These were the smallest tumors (mean overall size, 1.9 cm; mean invasion size 1.7 cm), but carried the worst prognosis (3-y survival, 41%), presumably due to the pancreatobiliary histology/origin (in 86%); however, even this group had significantly better prognosis when compared with 113 ordinary pancreatic ductal adenocarcinomas (3 y, 11%; P<0.0001). (3) Peri-AMP-duodenal (5%): Massive exophytic, ulcero-fungating tumors growing into the duodenal lumen and eccentrically encasing the ampullary orifice with only minimal intra-ampullary luminal involvement. These were mostly of intestinal phenotype (75%) and some had mucinous features. Although these tumors were the largest (mean overall size 4.7 cm; and mean invasion size 3.4 cm), and had the highest incidence of lymph node metastasis (50%), they carried an intermediate prognosis (3-y survival, 69%) to that seen among a group of 55 nonampullary duodenal carcinoma controls. (4) AC-not otherwise specified ("papilla of Vater"; 55%): Ulcero-nodular tumors located at the papilla of Vater, which do not show the specific characteristics identified among the other 3 subtypes. In conclusion, ACs comprise 4 clinicopathologic subtypes that are prognostically distinct.

Entities:  

Mesh:

Year:  2012        PMID: 23026934     DOI: 10.1097/PAS.0b013e31826399d8

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  44 in total

1.  Immunohistochemical Predictors for Intestinal and Pancreatobiliary Types of Adenocarcinoma of The Ampulla of Vater.

Authors:  João Paulo Lemos da Silveira Santos; Carla Jorge Machado; Eduardo Paulino Junior; João Bernardo Sancio Rocha Rodrigues; Paula Teixeira Vidigal; Vivian Resende
Journal:  J Gastrointest Surg       Date:  2018-05-07       Impact factor: 3.452

2.  Genomic and proteomic characterization of ARID1A chromatin remodeller in ampullary tumors.

Authors:  Anca Nastase; Jin Yao Teo; Hong Lee Heng; Cedric Chuan Young Ng; Swe Swe Myint; Vikneswari Rajasegaran; Jia Liang Loh; Ser Yee Lee; London Lucien Ooi; Alexander Yaw Fui Chung; Pierce Kah Hoe Chow; Peng Chung Cheow; Wei Keat Wan; Rafy Azhar; Avery Khoo; Sam Xin Xiu; Syed Muhammad Fahmy Alkaff; Ioana Cutcutache; Jing Quan Lim; Choon Kiat Ong; Vlad Herlea; Simona Dima; Dan G Duda; Bin Tean Teh; Irinel Popescu; Tony Kiat Hon Lim
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

3.  Ampullary cancer: Evaluation of somatic and germline genetic alterations and association with clinical outcomes.

Authors:  Winston Wong; Maeve A Lowery; Michael F Berger; Yelena Kemel; Barry Taylor; Ahmet Zehir; Preethi Srinivasan; Chaitanya Bandlamudi; Joanne Chou; Marinela Capanu; Anna Varghese; Kenneth H Yu; Christine A Iacobuzio-Donahue; Jinru Shia; David S Klimstra; William R Jarnagin; Zsofia K Stadler; Eileen M O'Reilly
Journal:  Cancer       Date:  2019-01-08       Impact factor: 6.860

4.  Whipple made simple for surgical pathologists: orientation, dissection, and sampling of pancreaticoduodenectomy specimens for a more practical and accurate evaluation of pancreatic, distal common bile duct, and ampullary tumors.

Authors:  N Volkan Adsay; Olca Basturk; Burcu Saka; Pelin Bagci; Denizhan Ozdemir; Serdar Balci; Juan M Sarmiento; David A Kooby; Charles Staley; Shishir K Maithel; Rhonda Everett; Jeanette D Cheng; Duangpeng Thirabanjasak; Donald W Weaver
Journal:  Am J Surg Pathol       Date:  2014-04       Impact factor: 6.394

5.  Non-ampullary-duodenal carcinomas: clinicopathologic analysis of 47 cases and comparison with ampullary and pancreatic adenocarcinomas.

Authors:  Yue Xue; Alessandro Vanoli; Serdar Balci; Michelle M Reid; Burcu Saka; Pelin Bagci; Bahar Memis; Hyejeong Choi; Nobuyike Ohike; Takuma Tajiri; Takashi Muraki; Brian Quigley; Bassel F El-Rayes; Walid Shaib; David Kooby; Juan Sarmiento; Shishir K Maithel; Jessica H Knight; Michael Goodman; Alyssa M Krasinskas; Volkan Adsay
Journal:  Mod Pathol       Date:  2016-10-14       Impact factor: 7.842

6.  Sequencing of 279 cancer genes in ampullary carcinoma reveals trends relating to histologic subtypes and frequent amplification and overexpression of ERBB2 (HER2).

Authors:  Jaclyn F Hechtman; Weiguo Liu; Justyna Sadowska; Lisa Zhen; Laetitia Borsu; Maria E Arcila; Helen H Won; Ronak H Shah; Michael F Berger; Efsevia Vakiani; Jinru Shia; David S Klimstra
Journal:  Mod Pathol       Date:  2015-05-15       Impact factor: 7.842

7.  Tumour origin and R1 rates in pancreatic resections: towards consilience in pathology reporting.

Authors:  Munita Bal; Swapnil Rane; Sanjay Talole; Mukta Ramadwar; Kedar Deodhar; Prachi Patil; Mahesh Goel; Shailesh Shrikhande
Journal:  Virchows Arch       Date:  2018-08-08       Impact factor: 4.064

8.  Intrapancreatic distal common bile duct carcinoma: Analysis, staging considerations, and comparison with pancreatic ductal and ampullary adenocarcinomas.

Authors:  Raul S Gonzalez; Pelin Bagci; Olca Basturk; Michelle D Reid; Serdar Balci; Jessica H Knight; So Yeon Kong; Bahar Memis; Kee-Taek Jang; Nobuyuki Ohike; Takuma Tajiri; Sudeshna Bandyopadhyay; Alyssa M Krasinskas; Grace E Kim; Jeanette D Cheng; N Volkan Adsay
Journal:  Mod Pathol       Date:  2016-07-29       Impact factor: 7.842

9.  Substaging Nodal Status in Ampullary Carcinomas has Significant Prognostic Value: Proposed Revised Staging Based on an Analysis of 313 Well-Characterized Cases.

Authors:  Serdar Balci; Olca Basturk; Burcu Saka; Pelin Bagci; Lauren M Postlewait; Takuma Tajiri; Kee-Taek Jang; Nobuyuki Ohike; Grace E Kim; Alyssa Krasinskas; Hyejeong Choi; Juan M Sarmiento; David A Kooby; Bassel F El-Rayes; Jessica H Knight; Michael Goodman; Gizem Akkas; Michelle D Reid; Shishir K Maithel; Volkan Adsay
Journal:  Ann Surg Oncol       Date:  2015-03-18       Impact factor: 5.344

10.  Surgical Ampullectomy with Complete Resection of the Common Bile Duct: a New Procedure for Radical Resection of Non-invasive Ampulloma with Biliary Extension.

Authors:  Alain Sauvanet; Safi Dokmak; Jérôme Cros; Dominique Cazals-Hatem; Philippe Ponsot; Maxime Palazzo
Journal:  J Gastrointest Surg       Date:  2017-05-30       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.